iCAN
@ican.fi
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at
iCAN's Company Logos
iCAN's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#4B81D3
Havelock Blue
75, 129, 211
216, 61, 56
64, 39, 0, 17
#D4907A
New York Pink
212, 144, 122
15, 51, 65
0, 32, 42, 17
#201D52
Port Gore
32, 29, 82
243, 48, 22
61, 65, 0, 68
About iCAN
iCAN is a national R&D flagship brand that is revolutionizing the world of cancer medicine. Their mission is to tackle the challenges of cancer through cutting-edge research and innovation in digital health. By combining precision cancer medicine with digital technologies, iCAN aims to make groundbreaking discoveries and improve treatments for cancer patients.
At the heart of iCAN is the discovery platform, which links molecular profiling of tumors with comprehensive health data from cancer patients. This platform enables researchers to identify new targets and solutions for diagnosing and treating cancer. With a goal of profiling 15,000 samples across different cancer types by 2026, iCAN is driven by real-world impact and the ability to conduct broad studies.
What sets iCAN apart is their unwavering focus on the patient. They believe that by centering their research and innovation hub around the patient, they can accelerate world-class scientific innovation. Collaborative partnerships with researchers and the life science industry ensure that the patient remains at the forefront of everything iCAN does.
Stay up to date with the latest news and developments from iCAN as they continue to make strides in the field of precision cancer medicine.
